NYSE:HQL
Tekla Life Sciences Investors
- Stock
Last Close
16.06
06/11 21:10
Market Cap
397.95M
Beta: 0.83
Volume Today
105.41K
Avg: 77.50K
Dividend Yield
9.13%
Payout:62.47%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 10.14M - | ||||||||||
average payables | 2.15M - | 3.16M 46.52% | 1.71M 45.91% | 1.83M 7.16% | 2.59M 41.38% | 1.41M 45.40% | 2.55M - | 2.55M 0% | 895.50 99.96% | ||
average receivables | 683.38K - | 5.56M 713.70% | 4.94M 11.23% | 5.61M 13.55% | 7.58M 35.26% | 2.02M 73.32% | 108.78K 94.62% | 383.57K 252.60% | 2.83M 638.86% | 2.64M 6.92% | |
book value per share | 23.51 - | 20.00 14.91% | 21.84 9.15% | 20.40 6.56% | 17.36 14.89% | 20.28 16.77% | 21.58 6.41% | 17.17 20.44% | |||
capex per share | |||||||||||
capex to depreciation | |||||||||||
capex to operating cash flow | |||||||||||
cash per share | 0.00 - | 0.00 2,289.21% | 0.03 5,834.82% | 0.00 99.99% | 0.05 2,961,603.48% | 0.00 - | 0.00 52.96% | ||||
days of inventory on hand | |||||||||||
days payables outstanding | 271.97 - | 168.84 37.92% | 103.77 38.54% | 179.68 73.16% | |||||||
days sales outstanding | 349.59 - | 2.50K 615.90% | 0.09 100.00% | 136.99 144,422.04% | -20.90 115.26% | 0.22 101.04% | 0.80 267.26% | -2.20 376.08% | 78.27 3,651.40% | 0.97 98.76% | |
debt to assets | |||||||||||
debt to equity | |||||||||||
earnings yield | 0.09 - | -0.03 133.55% | 0.15 587.44% | 0.06 59.55% | -0.21 449.52% | 0.29 238.94% | 0.13 56.43% | -0.33 358.32% | |||
enterprise value | 443.14M - | 388.52M 12.33% | 458.13M 17.92% | 474.24M 3.52% | 332.49M 29.89% | 419.24M 26.09% | 504.60M 20.36% | 316.64M 37.25% | -477 100.00% | -1 99.79% | |
enterprise value over ebitda | 5.17 - | -19.39 475.16% | 3.25 116.75% | 7.78 139.51% | -4.72 160.62% | 3.41 172.22% | 7.82 129.52% | -3.03 138.71% | -0.00 100.00% | ||
ev to operating cash flow | |||||||||||
ev to sales | 335.05 - | 270.33 19.32% | 6.56 97.57% | 15.90 142.33% | -4.79 130.15% | 3.38 170.46% | 7.68 127.36% | -3.07 139.92% | -0.00 100.00% | -0.00 99.94% | |
free cash flow per share | |||||||||||
free cash flow yield | |||||||||||
graham net net | -0.21 - | 0.23 210.73% | -0.06 127.71% | 0.23 466.93% | 0.06 75.14% | 0.00 95.98% | 0.00 92.88% | -0.71 15,840.35% | |||
graham number | 32.99 - | 16.08 51.27% | 39.71 147.02% | 23.76 40.16% | 35.30 48.57% | 48.52 37.44% | 35.94 25.94% | 41.75 16.18% | |||
income quality | |||||||||||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -0.10 - | 0.47 547.00% | -0.05 111.47% | -0.11 108.73% | |||||||
interest debt per share | 2.30 - | -0.39 117.04% | 3.39 966.32% | 1.38 59.17% | |||||||
inventory turnover | |||||||||||
invested capital | 1 - | ||||||||||
market cap | 443.14M - | 388.53M 12.32% | 458.75M 18.07% | 474.24M 3.38% | 333.61M 29.65% | 419.24M 25.67% | 504.60M 20.36% | 316.64M 37.25% | |||
net current asset value | -3.75M - | 7.20M 292.29% | -1.35M 118.71% | 8.21M 709.27% | 2.27M 72.37% | 73.90K 96.74% | 144.66K 95.76% | -16.20M 11,297.81% | 5.05M 131.14% | -888.61K 117.61% | |
net debt to ebitda | -0.00 - | 0.00 10,872.56% | -0.00 968.18% | -0.00 99.98% | 0.02 2,368,542.05% | -0.00 - | 0.00 127.73% | -0.00 601.63% | |||
net income per share | 2.06 - | -0.57 127.91% | 3.21 659.00% | 1.23 61.68% | -3.19 359.35% | 5.16 261.76% | 2.66 48.45% | -4.51 269.65% | |||
operating cash flow per share | |||||||||||
payables turnover | 1.34 - | 2.16 61.08% | 3.52 62.71% | 2.03 42.25% | |||||||
receivables turnover | 1.04 - | 0.15 86.03% | 3.85K 2,640,292.71% | 2.66 99.93% | -17.46 755.37% | 1.68K 9,715.68% | 457.21 72.77% | -165.61 136.22% | 4.66 102.82% | 375.09 7,943.74% | |
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.09 - | -0.03 132.95% | 0.15 613.23% | 0.06 59.07% | -0.18 404.01% | 0.25 239.55% | 0.12 52.47% | -0.25 308.79% | 0.06 122.01% | 0.19 233.56% | |
revenue per share | 0.07 - | 0.07 3.13% | 3.27 4,617.90% | 1.28 60.85% | -3.14 345.26% | 5.20 265.78% | 2.71 47.96% | -4.45 264.50% | |||
roe | 0.09 - | -0.03 132.80% | 0.15 612.13% | 0.06 58.99% | -0.18 404.74% | 0.25 238.52% | 0.12 51.55% | -0.26 313.24% | 0.06 121.15% | 0.19 233.65% | |
roic | -0.01 - | -0.01 10.47% | -0.01 8.95% | -0.01 8.79% | -0.18 2,321.61% | 0.25 238.52% | 0.12 51.55% | -0.26 313.24% | 0.06 121.15% | ||
sales general and administrative to revenue | 0.19 - | 0.38 99.40% | 0.01 96.29% | 0.03 107.95% | -0.01 142.81% | 0.01 147.89% | 0.01 112.20% | -0.01 181.16% | 0.04 468.17% | 0.02 59.97% | |
shareholders equity per share | 23.51 - | 20.00 14.91% | 21.84 9.15% | 20.40 6.56% | 17.36 14.89% | 20.28 16.77% | 21.58 6.41% | 17.17 20.44% | |||
tangible asset value | 462.84M - | 414.97M 10.34% | 466.35M 12.38% | 475.49M 1.96% | 384.16M 19.21% | 484.17M 26.03% | 534.19M 10.33% | 397.90M 25.51% | 402.60M 1.18% | 459.69M 14.18% | |
tangible book value per share | 23.51 - | 20.00 14.91% | 21.84 9.15% | 20.40 6.56% | 17.39 14.78% | 20.30 16.76% | 22.02 8.46% | 17.17 22.04% | |||
working capital | -2.94M - | 7.76M 363.85% | -676.96K 108.72% | 8.84M 1,406.33% | 2.27M 74.34% | 73.90K 96.74% | 144.66K 95.76% | -4.48M 3,193.95% | 5.05M 212.72% | 1 100.00% |
All numbers in USD (except ratios and percentages)